Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$549M |
| 2 |
Procter & Gamble
PG
|
$422M |
| 3 |
Merck
MRK
|
$374M |
| 4 |
Amazon
AMZN
|
$345M |
| 5 |
Hasbro
HAS
|
$309M |
Top Sells
| 1 |
Walt Disney
DIS
|
$475M |
| 2 |
CELG
Celgene Corp
CELG
|
$415M |
| 3 |
Mastercard
MA
|
$322M |
| 4 |
Intuitive Surgical
ISRG
|
$320M |
| 5 |
PayPal
PYPL
|
$285M |
Sector Composition
| 1 | Technology | 26.63% |
| 2 | Healthcare | 17.13% |
| 3 | Financials | 11.91% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENV
176
DELISTED
ENVESTNET, INC.
ENV
| $261M | 0.13% |
3,741,561
-4,018
| -0.1% | -$280K |
|
177
Ryanair
RYAAY
$32.1B
| $259M | 0.13% |
7,396,140
-45,340
| -0.6% | -$1.59M |
|
178
RenaissanceRe
RNR
$11.3B
| $258M | 0.13% |
1,317,141
-119,540
| -8% | -$23.4M |
|
179
T-Mobile US
TMUS
$284B
| $258M | 0.13% |
3,284,833
+1,520,751
| +86% | +$119M |
|
180
Oracle
ORCL
$654B
| $257M | 0.13% |
4,842,392
-1,070,461
| -18% | -$56.7M |
|
181
Citigroup
C
$176B
| $256M | 0.13% |
3,207,813
-237,824
| -7% | -$19M |
|
182
Chevron
CVX
$310B
| $254M | 0.13% |
2,105,056
-28,142
| -1% | -$3.39M |
|
|
MRTX
183
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $252M | 0.13% |
1,957,784
-54,351
| -3% | -$7M |
|
184
Integra LifeSciences
IART
$1.25B
| $251M | 0.13% |
4,312,847
+1,086,385
| +34% | +$63.3M |
|
185
Visteon
VC
$3.41B
| $250M | 0.13% |
2,886,332
-2,837
| -0.1% | -$246K |
|
186
Waste Management
WM
$88.6B
| $248M | 0.13% |
2,172,826
+424,138
| +24% | +$48.3M |
|
187
Dollar General
DG
$24.1B
| $247M | 0.13% |
1,581,319
-247,675
| -14% | -$38.6M |
|
188
Cboe Global Markets
CBOE
$24.3B
| $242M | 0.12% |
2,015,858
-168,025
| -8% | -$20.2M |
|
189
Williams-Sonoma
WSM
$24.7B
| $240M | 0.12% |
6,547,838
-7,460
| -0.1% | -$274K |
|
|
RP
190
DELISTED
RealPage, Inc.
RP
| $240M | 0.12% |
4,464,626
-142,860
| -3% | -$7.68M |
|
|
GBT
191
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $238M | 0.12% |
2,998,895
+549,524
| +22% | +$43.7M |
|
192
Berkshire Hathaway Class B
BRK.B
$1.08T
| $234M | 0.12% |
1,031,521
-254,876
| -20% | -$57.7M |
|
193
Southern Company
SO
$101B
| $232M | 0.12% |
3,642,768
-115,629
| -3% | -$7.37M |
|
194
Parker-Hannifin
PH
$96.1B
| $229M | 0.12% |
1,111,377
-668,944
| -38% | -$138M |
|
195
HP
HPQ
$27.4B
| $226M | 0.12% |
11,013,377
+7,258,714
| +193% | +$149M |
|
196
NCR Voyix
VYX
$1.84B
| $226M | 0.12% |
10,466,160
+439,966
| +4% | +$9.49M |
|
197
Marvell Technology
MRVL
$54.6B
| $225M | 0.12% |
8,462,573
+3,330,794
| +65% | +$88.5M |
|
198
Cedar Fair
FUN
$2.53B
| $222M | 0.11% |
4,008,472
-108,941
| -3% | -$6.04M |
|
199
CarMax
KMX
$9.11B
| $221M | 0.11% |
2,526,270
+256,851
| +11% | +$22.5M |
|
200
Trane Technologies
TT
$92.1B
| $221M | 0.11% |
1,662,736
+1,208,968
| +266% | +$161M |
|